Your browser doesn't support javascript.
loading
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor.
J Med Chem ; 62(19): 8711-8732, 2019 10 10.
Article in En | MEDLINE | ID: mdl-31532644

Full text: 1 Database: MEDLINE Main subject: Receptors, Dopamine D1 / Isoquinolines Limits: Animals / Humans Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Receptors, Dopamine D1 / Isoquinolines Limits: Animals / Humans Language: En Year: 2019 Type: Article